Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy

Intern Med. 2017;56(12):1563-1567. doi: 10.2169/internalmedicine.56.8055. Epub 2017 Jun 15.

Abstract

As a treatment for superficial transitional cell carcinoma, Bacillus Calmette-Guerin (BCG) intravesical instillation can rarely cause unpredictable systemic side effects. We describe a patient admitted due to continuous pyrexia and general fatigue. He was previously treated with intravesical BCG. Laboratory data indicated a hepatic disorder, and chest computed tomography revealed extensive bilateral miliary nodules. Transbronchial lung biopsy specimens showed several small noncaseating granulomas. The diagnosis was unsolved on the basis of acid fast staining, polymerase chain reaction and microbiological cultures, so we considered the possibility of BCG side effect-induced granuloma. Two months after treatment with antituberculous agents and corticosteroids, his clinical symptoms were improved.

Keywords: Bacillus Calmette-Guerin; intravesical instillation; miliary tuberculosis; noncaseating granulomas.

MeSH terms

  • Adjuvants, Immunologic / adverse effects*
  • Administration, Intravesical
  • Antitubercular Agents
  • BCG Vaccine / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Tomography, X-Ray Computed
  • Tuberculosis, Miliary / drug therapy
  • Tuberculosis, Miliary / etiology*

Substances

  • Adjuvants, Immunologic
  • Antitubercular Agents
  • BCG Vaccine